Why Medications Matter Before an Iboga Retreat

If you're considering an iboga retreat, one of the first things you'll be asked about is what you're taking. That covers prescriptions, supplements, recreational substances, and alcohol. For some people, the answer means weeks of preparation before they can safely sit with the medicine.

This can feel frustrating, especially if you're ready for change now. But preparation isn't a formality. It's one of the most important safety steps in iboga work, and understanding why can make the waiting easier.

Iboga is powerful medicine, and it affects the heart

Iboga is a root bark from Central Africa, held sacred for generations in the Bwiti tradition of Gabon. Its main active compound, ibogaine, affects many systems in the body at once. That breadth is part of why people describe such profound experiences with it. It's also why iboga has to be approached carefully.

The most important physical effect to understand is on the heart. Ibogaine can temporarily lengthen the heart's electrical cycle, known as the QT interval. In a healthy heart, with the right screening and supervision, this is manageable. But when other substances that also affect the QT interval are in the body at the same time, the effects can stack, raising the risk of dangerous heart rhythms.

When serious incidents have happened with iboga, they have often involved pre-existing heart conditions or other drugs still in a person's system. That's why careful screening and medication review aren't optional.

Substances that need to be addressed before a retreat

Every person's situation is different, and your full medical history will be reviewed during intake. These are the main categories that come up.

Long-acting opioids: methadone, fentanyl, and buprenorphine

Methadone stays in the body for a long time, and it affects the QT interval too. Fentanyl can build up in fatty tissue and linger longer than people expect. Buprenorphine (Suboxone) binds tightly to opioid receptors, which can interfere with the process.

Benzodiazepines

Medications like alprazolam (Xanax), clonazepam, and lorazepam carry their own risks with iboga, and stopping them suddenly can cause seizures. Benzodiazepines must be tapered slowly with a prescriber's support, never stopped cold. A person should consider several weeks off the medication before iboga.

Alcohol

Alcohol withdrawal can be medically dangerous in its own right. If you drink heavily or daily, withdrawal needs to be managed with medical care before a retreat, not during it.

Stimulants

Cocaine, methamphetamine, and prescription stimulants put extra strain on the heart. A period of abstinence before a retreat gives your cardiovascular system time to settle.

Antidepressants and psychiatric medications

Some antidepressants, particularly certain SSRIs, change how the body breaks down ibogaine, which can raise its levels unpredictably. Some antipsychotics and mood medications also affect the QT interval. If you take psychiatric medication, any change must happen gradually and under the care of your prescriber. Stopping these medications abruptly can cause withdrawal effects and a return of symptoms, so this step deserves time and support.

Other medications that affect the heart rhythm

A surprising number of everyday medications can lengthen the QT interval, including some antibiotics, antifungals, anti-nausea drugs, antihistamines, and heart medications. This is why we ask for a complete list, including anything you take occasionally, and why an ECG is part of screening.

Supplements

Herbal supplements and even some common ones can interact with iboga. Include everything on your intake form, even if it seems minor.

Never stop a medication on your own

This is the most important line in this article. Please don't stop or change any prescribed medication without talking to the doctor who prescribed it. Some medications are dangerous to stop suddenly, and others treat conditions that need ongoing care. Our team can explain what's needed for a retreat, but changes to your medications should always be made with your own medical provider.

If a medication you rely on can't be safely changed, iboga may not be the right path for you right now, and that's okay. Being honest about that is part of caring for you.

What screening looks like

Before you're accepted to a Medicine Spirit retreat, you'll fill out a detailed intake questionnaire and submit an ECG. We may ask follow-up questions or request records from your doctor. The goal is to know as much as possible so we can keep you safe.

After the retreat: a note on tolerance

For anyone who has been using opioids, this matters as much as preparation. After iboga, your tolerance may be much lower than before. If you return to your previous dose, you face a real risk of overdose. Integration support, a plan for the weeks after, and people around you who know what you're working through all make a difference.

Preparation is part of the medicine

In the Bwiti tradition, iboga is approached with intention and respect, not casually. The weeks you spend preparing, clearing your body, getting honest about what you carry, and setting your intentions are already part of the work. By the time you arrive, you've shown yourself that you're ready.

If you have questions about your medications or your eligibility, reach out to info@medicinespirit.org. We're happy to talk it through.

This article is for general information and isn't medical advice. Please consult your healthcare provider about your specific medications and health needs.

Sources

Alper, K. R., Stajić, M., & Gill, J. R. (2012). Fatalities temporally associated with the ingestion of ibogaine. Journal of Forensic Sciences, 57(2), 398–412. https://pubmed.ncbi.nlm.nih.gov/22268458/

Koenig, X., & Hilber, K. (2015). The anti-addiction drug ibogaine and the heart: A delicate relation. Molecules, 20(2), 2208–2228. https://www.mdpi.com/1420-3049/20/2/2208

Brunt, T. M., et al. (2026). Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias. Addiction. https://pmc.ncbi.nlm.nih.gov/articles/PMC13155281/

Global Ibogaine Therapy Alliance. (2016). Clinical Guidelines for Ibogaine-Assisted Detoxification (v1.1). https://ibogaineguidelines.com/

Strang, J., et al. (2003). Loss of tolerance and overdose mortality after inpatient opiate